A New Anatomical Classification of Portal Vein Location of Pancreas Tumors
1 other identifier
interventional
43
0 countries
N/A
Brief Summary
In this retrospective study, we recorded the location of pancreatic tumors and relation/proximity to the portal vein. The surgical difficulty and requirement of additional interventions were also evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2014
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 31, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedMay 11, 2022
April 1, 2022
4.4 years
May 31, 2020
May 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
peri-operative or postoperative complication
surgical complications observed during both operative and postoperative period
up to one month
Secondary Outcomes (1)
hospital stay
up to one month
Other Outcomes (1)
in hospital mortality
up to two months
Study Arms (3)
Level 1
OTHERThose tumors located superior to the portal confluence were classified as Level I,
Level II
OTHERthose tumors located on the confluence (involving the confluence) located on the portal confluence
Level III
OTHERthose tumors located inferior to the portal confluence
Interventions
For Level I-II tumors, in case of segmental resection of PV/SMV, the reconstruction was performed by an end-to-end anastomosis either by direct suture (for defect under 2 cm) or by using an interposition venous or prosthetic graft. For this purpose, autologous grafting we used internal jugular vein and cadaveric iliac vein and alternatively, synthetic PTFE graft was also used.
For Level I-II tumors, in case of segmental resection of PV/SMV, the reconstruction was performed by an end-to-end anastomosis either by direct suture (for defect under 2 cm) or by using an interposition venous or prosthetic graft. For this purpose, autologous grafting we used internal jugular vein and cadaveric iliac vein and alternatively, synthetic PTFE graft was also used.
Regarding Level III tumors, complete resection of the tumor was done either by tangential excision or by partial venous excision and subsequent reconstruction. To maintain a secure anastomosis, the mesenteric root was mobilized completely or/and splenic vein was divided.
Eligibility Criteria
You may qualify if:
- This retrospective cohort study identified all consecutive patients with T3 (stage IIA to III) adenocarcinoma of the head of the pancreas, who underwent concomitant venous (PV/SMV) resection.
You may not qualify if:
- Those patients with locally advanced tumors that were not responded to neoadjuvant therapy were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc Prof
Study Record Dates
First Submitted
May 31, 2020
First Posted
June 4, 2020
Study Start
May 1, 2014
Primary Completion
October 1, 2018
Study Completion
May 1, 2019
Last Updated
May 11, 2022
Record last verified: 2022-04